As of June 12, 2018 our Privacy Policy has been updated. For individuals in the European Union, CIL uses cookies on this website. Please review the new privacy statement to see how. By continuing to use this website you agree to us using cookies in accordance with our privacy statement. Click here for the new privacy statement..OK

Corporate Overview

Facilities

 

Sales and Service Worldwide

CIL products have contributed to advancements in drug discovery, environmental analysis, genomics and proteomics, and medical diagnostic research. 


 

The CIL Group is comprised of five companies: 

Cambridge Isotope Laboratories, Inc.
Deuterated NMR solvents, stable isotope-labeled chemicals and gases, as well as specific cGMP products

CIL Isotope Separations, LLC (CIS)
Separation of 13C and 18O

Euriso-Top
Deuterated solvents and stable isotope-labeled compounds (nonradioactive)

ABX GmbH
PET precursors, FDG reagents kits, PET and SPECT precursors and reference standards, manufacturing of reagents kits and cassettes, FDG, FLT, F-Choline, NaF, F-Miso, FES and FET production

CIL Canada
Carbohydrates, enriched media, and amino acids for drug-discovery applications

Facilities | Cambridge Isotope Laboratories
stable isotope, stable isotopes, stable isotope manufacturees, drug discovery, environmental analysis , genomic, proteomics, medical diagnostic research
CIL stable isotope labeled products have contributed to advancements in drug discovery, environmental analysis, genomics and proteomics, and medical diagnostic research.